Insmed
INSM
$25.59
Share price
3.52%
Change (1 day)
26.87%
Change (1 year)
Categories
Insmed (INSM) - Cash on Hand
Cash on Hand as of December 2023 : $0.78 B
According to Insmed's latest financial reports the company has $0.78 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Insmed - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.78 B | -32.03% |
| 2022-12-31 | $1.14 B | 60.2% |
| 2021-12-31 | $0.71 B | 34.54% |
| 2020-12-31 | $0.53 B | 9.3% |
| 2019-12-31 | $0.48 B | -1.54% |
| 2018-12-31 | $0.49 B | 29.88% |
| 2017-12-31 | $0.38 B | 134.43% |
| 2016-12-31 | $0.16 B | -42.52% |
| 2015-12-31 | $0.28 B | 77.66% |
| 2014-12-31 | $0.15 B | 39.8% |
| 2013-12-31 | $0.11 B | 22.55% |
| 2012-12-31 | $92.93 M | 21.85% |
| 2011-12-31 | $76.27 M | -29.41% |
| 2010-12-31 | $0.10 B | -11.57% |
| 2009-12-31 | $0.12 B | 4997.25% |
| 2008-12-31 | $2.39 M | -85.45% |
| 2007-12-31 | $16.47 M | -31.66% |
| 2006-12-31 | $24.11 M | 28.02% |
| 2005-12-31 | $18.83 M | 104.24% |
| 2004-12-31 | $9.22 M | -68.77% |
| 2003-12-31 | $29.52 M | 8.01% |
| 2002-12-31 | $27.33 M | -46.66% |
| 2001-12-31 | $51.25 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.69 B | 1,142.11% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | $7.26 B | 830.75% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $11.21 B | 1,337.42% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $1.67 B | 114.78% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.17 B | -77.90% | 🇺🇸 USA |
 Array Technologies ARRY | $0.24 B | -68.08% | 🇺🇸 USA |